Navigation Links
Tengion Provides Business Update and Reports Third Quarter 2011 Financial Results
Date:11/14/2011

tilize other tissues of the body for a purpose to which they are poorly suited, procure donor organs or administer anti-rejection medications.  An initial clinical trial is ongoing for the Company's lead product candidate, the Neo-Urinary Conduit, an autologous implant that is intended to catalyze regeneration of native-like bladder tissue for bladder cancer patients requiring a urinary diversion following bladder removal.  The Company's lead preclinical candidate is the Neo-Kidney Augment, which is designed to delay or prevent the need for dialysis or transplantation in patients at risk for kidney failure.  Tengion has also applied its technology in two Phase II clinical trials for Tengion's Neo-Bladder Augment for the treatment of neurogenic bladder.  Tengion has worldwide rights to its product candidates.

Forward-Looking Statements Certain statements set forth above may constitute forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995, including, but not limited to the Company's: (i) search for a new chief executive officer; (ii) expectations regarding the initial clinical trial of the Neo-Urinary Conduit and (iii) expectations regarding planned preclinical studies of the Neo-Kidney Augment. Although Tengion believes that these statements are based upon reasonable assumptions within the bounds of its knowledge of its business and operations, there are a number of factors that may cause actual results to differ from these statements. For instance there can be no assurance that: (i) the Company will be able to find a suitable candidate for the position of chief executive officer or that the Company will be able to retain such person on mutually agreeable terms; (ii) the Company will be able to successfully enroll patients in its clinical trials, including its initial clinical trial for the Neo-Urinary Conduit; (iii)  the Company's Neo-Urinary Conduit clinical trial will not be
'/>"/>

SOURCE Tengion, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10

Related medicine technology :

1. Tengion Appoints Scott Flora to Board of Directors
2. Tengion Appoints Diane Jorkasky, M.D., to its Board of Directors
3. Tengion Provides Update on Neo-Urinary Conduit Clinical Trial
4. Tengion Announces FDA Orphan-Drug Designation for Neo-Urinary Conduit
5. Tengion Presents New Data in Nine Posters and Two Oral Presentations at TERMIS North America Annual Meeting
6. Tengion Advances Clinical Trial for Neo-Urinary Conduit™ in Bladder Cancer Patients
7. Tengion Provides Business Update and Reports Third Quarter 2010 Financial Results
8. Tengion Reviews Pipeline Progress at First Analyst and Investor Meeting; Strategic & Clinical Updates Provided for Regenerative Medicine Programs
9. Tengion Announces First Implantation of Neo-Urinary Conduit™ in Initial Clinical Trial in Patients with Bladder Cancer
10. Tengion Presents New Data Demonstrating Functional Regeneration in a Diabetic Chronic Kidney Failure Model at the International Society for Cellular Therapy
11. Tengion Appoints Sunita B. Sheth, M.D., Chief Medical Officer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/4/2015)... 2015  Isis Pharmaceuticals, Inc. (Nasdaq: ISIS ) ... million for the three and six months ended June ... $12.1 million and $43.4 million for the same periods ... primarily by the more than $90 million of revenue ... upfront payment from Bayer to license  ISIS-FXI Rx .  ...
(Date:8/4/2015)... Aug. 4, 2015  Armada Health Care ... Medical School,s Clinical Pharmacy Services business unit ... protocols and therapy interventions within the ArmadaOne ... Specialty medication therapy management is an essential ... optimal patient outcomes are achieved through timely ...
(Date:8/4/2015)... 2015  Delcath Systems, Inc. (NASDAQ: DCTH ), ... oncology with an emphasis on the treatment of primary ... data from studies in Europe ... CHEMOSAT ® Delivery System (CHEMOSAT) will be presented at ... which will be held in Marseille, France ...
Breaking Medicine Technology:Isis Reports Financial Results And Highlights For Second Quarter 2015 2Isis Reports Financial Results And Highlights For Second Quarter 2015 3Isis Reports Financial Results And Highlights For Second Quarter 2015 4Isis Reports Financial Results And Highlights For Second Quarter 2015 5Isis Reports Financial Results And Highlights For Second Quarter 2015 6Isis Reports Financial Results And Highlights For Second Quarter 2015 7Isis Reports Financial Results And Highlights For Second Quarter 2015 8Isis Reports Financial Results And Highlights For Second Quarter 2015 9Isis Reports Financial Results And Highlights For Second Quarter 2015 10Isis Reports Financial Results And Highlights For Second Quarter 2015 11Isis Reports Financial Results And Highlights For Second Quarter 2015 12Isis Reports Financial Results And Highlights For Second Quarter 2015 13Isis Reports Financial Results And Highlights For Second Quarter 2015 14Isis Reports Financial Results And Highlights For Second Quarter 2015 15Isis Reports Financial Results And Highlights For Second Quarter 2015 16Armada Health Care collaborates with University of Massachusetts Medical School for ArmadaOne Specialty Pharmacy Platform 2Armada Health Care collaborates with University of Massachusetts Medical School for ArmadaOne Specialty Pharmacy Platform 3Delcath Announces Acceptance of Abstracts for Presentation at the European Association of Dermato Oncology Annual Congress 2Delcath Announces Acceptance of Abstracts for Presentation at the European Association of Dermato Oncology Annual Congress 3Delcath Announces Acceptance of Abstracts for Presentation at the European Association of Dermato Oncology Annual Congress 4
... YORK and KANSAS CITY, Mo., Sept. 19, 2011 ... lower carbon dioxide emissions, Duane Reade today announced a ... all-electric commercial trucks to its delivery fleet. With the ... first retail pharmacy in the United States to choose ...
... 2011 Delcath Systems, Inc. (NASDAQ: DCTH ) ... Healthcare Conference on Wednesday, September 28, 2011 at 11:00 A.M. ... will provide an overview of the Company,s business strategy and ... is by invitation only.  Delcath will offer a live webcast ...
Cached Medicine Technology:Duane Reade and Smith Electric Vehicles Partner to Bring All-Electric Delivery Vehicles to New York's Streets 2Duane Reade and Smith Electric Vehicles Partner to Bring All-Electric Delivery Vehicles to New York's Streets 3Delcath to Present at the JMP Securities Healthcare Conference on September 28, 2011 2Delcath to Present at the JMP Securities Healthcare Conference on September 28, 2011 3
(Date:8/4/2015)... ... August 04, 2015 , ... ... examination now offered by the world renowned Beverly Hills facelift surgeon , ... through cosmetic surgery techniques helps individuals to achieve an outer appearance that meets ...
(Date:8/4/2015)... Denver, CO (PRWEB) , ... August 04, 2015 ... ... for skilled nursing homes and other long-term care facilities, today announced details of ... (QAPI) for nursing homes and centers. , Providigm’s QAPI Accreditation program , ...
(Date:8/4/2015)... (PRWEB) , ... August 04, ... ... its HealthCenter personal health record (PHR) product has achieved Office of the ... Inpatient EHR Certification from Drummond Group. HealthCenter delivers the highest quality personal ...
(Date:8/4/2015)... ... ... METTLER TOLEDO has announced an upcoming online symposium entitled ... and Merck. This free online seminar will be held on September 24, ... decisions with limited process understanding. Established methods have been developed to facilitate ...
(Date:8/4/2015)... ... ... The results of a three year clinical trial for the Argus II, a ... blindness, were published on June 23, 2015 in Ophthalmology , the journal of ... more commonly known as the “bionic eye,” is safe and effective for long-term treatment ...
Breaking Medicine News(10 mins):Health News:Beverly Hills Surgeon, Dr. Paul Nassif, is Now Offering Personal Consultations with Full Examinations for Facial Plastic Surgeries 2Health News:Beverly Hills Surgeon, Dr. Paul Nassif, is Now Offering Personal Consultations with Full Examinations for Facial Plastic Surgeries 3Health News:Nursing Homes Achieving New Advanced Accreditation See Improved Measures of Quality, Better Occupancy Rates 2Health News:Nursing Homes Achieving New Advanced Accreditation See Improved Measures of Quality, Better Occupancy Rates 3Health News:MedicaSoft's HealthCenter Earns ONC-HIT Certification from Drummond Group 2Health News:MedicaSoft's HealthCenter Earns ONC-HIT Certification from Drummond Group 3Health News:METTLER TOLEDO Announces New Process Chemistry and Scale-up Online Seminar 2Health News:“Bionic Eye” Implant for the Blind Proved Safe and Effective at the End of a Three Year Clinical Trial 2
... National Government Services subsidiary Medicare ... York and Connecticut, INDIANAPOLIS, May 5 WellPoint, ... Inc.,subsidiary was selected by the Centers for Medicare & ... Jurisdiction 13,which includes the states of New York and ...
... kidney disease from high blood pressure did not keep ... of African-Americans studied, according to long-term results of a ... in the Archives of Internal Medicine. , The largest ... the African American Study of Kidney Disease and ...
... more with exclusive summer ... travel packages for 2008., SAN RAFAEL, ... Hotels & Restaurants Group announced today a,series of travel packages for ... KN Tranquility Suite(TM) offers opulent, comfort-inspired,surroundings in the heart of Chicago,s ...
... 5 ConforMIS, Inc., a privately,held company that ... treatment of osteoarthritis and joint damage, today,announced the ... Officer.,The addition fully rounds out the executive team, ... Chief Executive Officer and Phil Licari,as Chief Operating ...
... fewer brain bleeds than aspirin, study finds , , MONDAY, May ... good as aspirin at preventing recurrent stroke and it causes ... Peking University First Hospital in Beijing shows. , The trial ... to 18 months and 359 patients who took aspirin for ...
... prescriptions for $10, more women,s health offerings, and $4 ... BENTONVILLE, Ark., May 5 While health care,costs ... Stores, Inc.,(NYSE: WMT ) is furthering its efforts ... costs and providing ongoing savings,through its pharmacy offerings., ...
Cached Medicine News:Health News:WellPoint Wins Medicare Administrative Contract Worth up to $323 Million 2Health News:Kidney disease worsens in a fourth of African-Americans despite therapy for hypertension 2Health News:KN Tranquility Suite(TM) Hosts Spa Indulgences and High-Tea Service on the Magnificent Mile 2Health News:KN Tranquility Suite(TM) Hosts Spa Indulgences and High-Tea Service on the Magnificent Mile 3Health News:ConforMIS Completes Executive Team With Addition of CFO 2Health News:Anti-Clotting Drug as Good as Aspirin at Stopping Second Stroke 2Health News:Wal-Mart Launches Phase Three of $4 Prescription Program 2Health News:Wal-Mart Launches Phase Three of $4 Prescription Program 3Health News:Wal-Mart Launches Phase Three of $4 Prescription Program 4
... device for the qualitative detection of drug or ... device can detect up to nine of the ... minutes and requires only a few drops of ... maximize convenience and ease of use. TOX/See features ...
... hand-held, point-of-care device for the qualitative detection of ... The TOX/See device can detect up to nine ... to 8 minutes and requires only a few ... packaged to maximize convenience and ease of use. ...
... device for the qualitative detection of drug or ... device can detect up to nine of the ... minutes and requires only a few drops of ... maximize convenience and ease of use. TOX/See features ...
... is a 1-step, hand-held, point-of-care device for the ... human urine. The TOX/See device can detect ... drugs in 3 to 8 minutes and requires ... cassette is individually packaged to maximize convenience and ...
Medicine Products: